Which second-generation antihistamine, such as cetirizine (Zyrtec) or loratadine (Claritin), is more effective for treating allergic rhinitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comparing Second-Generation Antihistamines for Allergic Rhinitis

Cetirizine appears to be more effective than loratadine for treating allergic rhinitis symptoms, though it may cause slightly more sedation at recommended doses. 1

Efficacy Comparison

  • Among second-generation antihistamines, several studies have found cetirizine to be superior to loratadine for decreasing mean rhinitis symptom scores in seasonal allergic rhinitis, although in one study the differences were not statistically significant 1
  • In controlled environmental exposure studies, cetirizine produced significantly greater mean reductions than loratadine in both major symptom complex (37.4% vs 14.7%) and total symptom complex severity scores (36.7% vs 15.4%) 2, 3
  • Cetirizine demonstrated a more rapid onset of action (within 1 hour) compared to loratadine (3 hours) in controlled pollen challenge studies 3
  • In field studies conducted in outdoor parks during allergy season, cetirizine relieved rhinitis symptoms more effectively and quickly than loratadine 2

Sedation and Safety Profiles

  • There are important differences among second-generation antihistamines regarding sedative properties 1:

    • Fexofenadine, loratadine, and desloratadine do not cause sedation at recommended doses 1
    • Loratadine and desloratadine may cause sedation at doses exceeding recommended levels 1
    • Cetirizine may cause sedation at recommended doses 1
  • Cetirizine 10 mg may be associated with mild drowsiness (13.7% for patients age 12+ years) compared with placebo (6.3%), but typically without performance impairment 1

  • In some studies, higher doses of cetirizine (10 mg or above) have been associated with performance impairment 1

  • In comparative studies, the incidence of somnolence with cetirizine was greater than that of fexofenadine in some clinical trials and greater than loratadine or fexofenadine in a postmarketing surveillance study 4

Clinical Application

  • For patients where efficacy is the primary concern, cetirizine may be preferred due to its superior symptom control and faster onset of action 2, 3
  • For patients where minimal sedation is critical (e.g., those who drive, operate machinery, or need optimal cognitive function), loratadine may be preferred 1
  • Dose titration of cetirizine (starting at 5 mg and increasing as needed up to 20 mg) may allow for greater efficacy in patients with refractory symptoms of allergic rhinitis 5
  • Both cetirizine and loratadine demonstrate anti-inflammatory effects beyond histamine blockade, including reduction in eosinophil infiltration, inflammatory mediators, and ICAM-1 expression on nasal epithelial cells 6

Important Considerations

  • Intranasal corticosteroids are more effective than oral antihistamines for overall control of allergic rhinitis symptoms, particularly nasal congestion 1
  • For patients with both allergic rhinitis and asthma, leukotriene receptor antagonists (e.g., montelukast) may be considered 1
  • In patients with severe symptoms, combination therapy may be necessary, such as an antihistamine with a decongestant or an intranasal corticosteroid 1
  • Second-generation antihistamines are generally preferred over first-generation antihistamines due to less sedation, performance impairment, and anticholinergic effects 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dose-ranging comparative evaluation of cetirizine in patients with seasonal allergic rhinitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1995

Research

Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.